132 related articles for article (PubMed ID: 1301645)
1. [Study of induced effects by selective CCKB agonists cholecystokinin in the nociception and behavior in rodents].
Dauge V; Derrien M; Durieux C; Noble F; Corringer PJ; Roques BP
Therapie; 1992 Nov; 47(6):531-9. PubMed ID: 1301645
[TBL] [Abstract][Full Text] [Related]
2. Investigation of behavioral and electrophysiological responses induced by selective stimulation of CCKB receptors by using a new highly potent CCK analog, BC 264.
Dauge V; Bohme GA; Crawley JN; Durieux C; Stutzmann JM; Feger J; Blanchard JC; Roques BP
Synapse; 1990; 6(1):73-80. PubMed ID: 2399491
[TBL] [Abstract][Full Text] [Related]
3. [3H]pBC 264, a suitable probe for studying cholecystokinin-B receptors: binding characteristics in rodent brains and comparison with [3H]SNF 8702.
Durieux C; Ruiz-Gayo M; Corringer PJ; Bergeron F; Ducos B; Roques BP
Mol Pharmacol; 1992 Jun; 41(6):1089-95. PubMed ID: 1614411
[TBL] [Abstract][Full Text] [Related]
4. Stimulation of delta-opioid receptors reduces the in vivo binding of the cholecystokinin (CCK)-B-selective agonist [3H]pBC 264: evidence for a physiological regulation of CCKergic systems by endogenous enkephalins.
Ruiz-Gayo M; Durieux C; Fournié-Zaluski MC; Roques BP
J Neurochem; 1992 Nov; 59(5):1805-11. PubMed ID: 1357099
[TBL] [Abstract][Full Text] [Related]
5. Structure-based design of new constrained cyclic agonists of the cholecystokinin CCK-B receptor.
Blommaert AG; Dhôtel H; Ducos B; Durieux C; Goudreau N; Bado A; Garbay C; Roques BP
J Med Chem; 1997 Feb; 40(5):647-58. PubMed ID: 9057851
[TBL] [Abstract][Full Text] [Related]
6. Role of cholecystokinin-A and cholecystokinin-B receptors in anxiety.
Hernandez-Gómez AM; Aguilar-Roblero R; Pérez de la Mora M
Amino Acids; 2002; 23(1-3):283-90. PubMed ID: 12373548
[TBL] [Abstract][Full Text] [Related]
7. The use of topographical constraints in receptor mapping: investigation of the topographical requirements of the tryptophan 30 residue for receptor binding of Asp-Tyr-D-Phe-Gly-Trp-(N-Me)Nle-Asp-Phe-NH2 (SNF 9007), a cholecystokinin (26-33) analogue that binds to both CCK-B and delta-opioid receptors.
Boteju LW; Nikiforovich GV; Haskell-Luevano C; Fang SN; Zalewska T; Stropova D; Yamamura HI; Hruby VJ
J Med Chem; 1996 Sep; 39(20):4120-4. PubMed ID: 8831778
[TBL] [Abstract][Full Text] [Related]
8. In vivo binding affinities of cholecystokinin agonists and antagonists determined using the selective CCKB agonist [3H]pBC 264.
Durieux C; Ruiz-Gayo M; Roques BP
Eur J Pharmacol; 1991 Dec; 209(3):185-93. PubMed ID: 1797561
[TBL] [Abstract][Full Text] [Related]
9. Analysis of strain difference in behavior to Cholecystokinin (CCK) receptor mediated drugs in PVG hooded and Sprague-Dawley rats using elevated plus-maze test apparatus.
Farook JM; Zhu YZ; Wang Q; Moochhala SM; Lee L; Wong PT
Neurosci Lett; 2004 Apr; 358(3):215-9. PubMed ID: 15039119
[TBL] [Abstract][Full Text] [Related]
10. SNF9007: a novel analgesic that acts simultaneously at delta 1, delta 2 and mu opioid receptors.
Williams CL; Rosenfeld GC; Dafny N; Fang SN; Hruby VJ; Bowden G; Cullinan CA; Burks TF
J Pharmacol Exp Ther; 1994 May; 269(2):750-5. PubMed ID: 8182541
[TBL] [Abstract][Full Text] [Related]
11. [The participation of CCK-8-ergic mechanisms in the regulation of emotional behavior in rodents].
Kharro IaE; Pyl'd MA; Vasar EE; Allikmets LKh
Zh Vyssh Nerv Deiat Im I P Pavlova; 1989; 39(5):877-83. PubMed ID: 2603555
[TBL] [Abstract][Full Text] [Related]
12. Opposite effects of CCK(B) agonists in grooming behaviour in rats: further evidence for two CCK(B) subsites.
Ladurelle N; Sebret A; Garbay C; Roques BP; Daugé V
Br J Pharmacol; 1998 Jul; 124(6):1091-8. PubMed ID: 9720778
[TBL] [Abstract][Full Text] [Related]
13. The CCK-B agonist, BC264, increases dopamine in the nucleus accumbens and facilitates motivation and attention after intraperitoneal injection in rats.
Ladurelle N; Keller G; Blommaert A; Roques BP; Daugé V
Eur J Neurosci; 1997 Sep; 9(9):1804-14. PubMed ID: 9383203
[TBL] [Abstract][Full Text] [Related]
14. Increased cholecystokinin release in the rat anterior cingulate cortex during carrageenan-induced arthritis.
Erel U; Arborelius L; Brodin E
Brain Res; 2004 Oct; 1022(1-2):39-46. PubMed ID: 15353211
[TBL] [Abstract][Full Text] [Related]
15. Peptidomimetics as receptors agonists or peptidase inhibitors: a structural approach in the field of enkephalins, ANP and CCK.
Roques BP
Biopolymers; 1992 Apr; 32(4):407-10. PubMed ID: 1320419
[TBL] [Abstract][Full Text] [Related]
16. Involvement of dorsolateral periaqueductal gray cholecystokinin-2 receptors in the regulation of a panic-related behavior in rats.
Bertoglio LJ; Zangrossi H
Brain Res; 2005 Oct; 1059(1):46-51. PubMed ID: 16168394
[TBL] [Abstract][Full Text] [Related]
17. Systemic and intra-dorsal periaqueductal gray injections of cholecystokinin sulfated octapeptide (CCK-8s) induce a panic-like response in rats submitted to the elevated T-maze.
Zanoveli JM; Netto CF; Guimarães FS; Zangrossi H
Peptides; 2004 Nov; 25(11):1935-41. PubMed ID: 15501525
[TBL] [Abstract][Full Text] [Related]
18. The CCK-system mediates adaptation to novelty-induced stress in the rat: a pharmacological evidence.
Ballaz SJ; Akil H; Watson SJ
Neurosci Lett; 2007 Nov; 428(1):27-32. PubMed ID: 17950531
[TBL] [Abstract][Full Text] [Related]
19. The selective CCK-B agonist, BC 264 injected in the antero-lateral part of the nucleus accumbens, reduces the spontaneous alternation behaviour of rats.
Daugé V; Derrien M; Blanchard JC; Roques BP
Neuropharmacology; 1992 Jan; 31(1):67-75. PubMed ID: 1542405
[TBL] [Abstract][Full Text] [Related]
20. Cholecystokinin-8 regulation of NGF concentrations in adult mouse brain through a mechanism involving CCK(A) and CCK(B) receptors.
Tirassa P; Stenfors C; Lundeberg T; Aloe L
Br J Pharmacol; 1998 Mar; 123(6):1230-6. PubMed ID: 9559909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]